,for, Item ID-
  • #1195617
  • Sanofi Pasteur #63361024310

Vaxelis™ Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine 15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL Injection 0.5 mL

VAXELIS DTAP-IPV/HIB/HEPB, SDV0.5ML (10/CT)

Sanofi Pasteur 63361024310
Vaxelis™ Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine 15 Lf - 5 Lf - 20 mcg - 62 DU - 53 mcg - 10 mcg / 0.5 mL Injection 0.5 mL
Compare

Features

  • VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
  • VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
  • VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit
  • More …
  Log In to Order
or
 View Alternatives

Product Specifications

Features
  • VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is a vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib).
  • VAXELIS is approved for use as a 3-dose series in children 6 weeks through 4 years of age (prior to the 5th birthday).
  • VAXELIS may reduce the number of shots that infants and parents must endure in the first 6 months—with as few as 2 injections per visit
Compare Products (0) Clear Compare